Aniline-derived ligands for the thyroid receptor

Details for Australian Patent Application No. 2001230929 (hide)

Owner Bristol-Myers Squibb Co.

Inventors Zhang, Minsheng; Ryono, Dennis E.; Friends, Todd Jason

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001230929

PCT Pub. Number WO01/60784

Priority 60/183,223 17.02.00 US

Filing date 12 January 2001

Wipo publication date 27 August 2001

Acceptance publication date 23 September 2004

International Classifications

C07C 235/74 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 031/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

C07C 235/76 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

23 September 2004 Application Accepted

  Published as AU-B-2001230929

20 January 2005 Standard Patent Sealed

3 September 2009 Assignment Registered

  Bristol-Myers Squibb Co. The patent has been assigned to Karo Bio AB; Bristol-Myers Squibb Co.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001230930

2001230928